Top Warning Letter Trends of 2019 By Sam | December 25, 2019 The FDA’s warning letters for 2019 once again targeted many familiar GMP failures, such as quality units that either lacked or failed to follow written procedures. Source: Drug Industry Daily Posted in Drug Industry Daily